Antigen Selection Articles & Analysis: Older
12 articles found
This specificity is achieved by linking a radioactive isotope to a monoclonal antibody or small molecule that targets specific cancer antigens. When administered, the RDCs selectively bind to the cancer cells, allowing for localized delivery of radiation. ...
Target Selection: The initial step in ADC development is identifying an appropriate target. Tumor-associated antigens (TAAs) are typically selected based on their expression in cancer cells versus normal tissues. ...
They have the advantages of small size, high stability, and good penetration, and therefore have a wide range of application prospects in the fields of clinical treatment, diagnostic reagent development, etc.Characteristics of NanobodiesThe size of nanobodies usually ranges between 10-15kDa, which is only 1/10 of the size of regular antibodies. Their unique antigen-binding ...
Type of Aluminum Adjuvants The two main types of aluminum adjuvants currently included in licensed human vaccines are aluminum hydroxide and aluminum phosphate. The selection of AH adjuvants versus AP adjuvants in vaccine formulations is highly dependent on the nature of the antigen and the requirements for adsorption to achieve an optimal immune response. ...
Peptide vaccines are increasingly seen as an economically efficient and safe approach to circumvent this issue.Peptide Vaccine DevelopmentThe vaccine development process is a challenging multi-step process: Antigen selection→Epitope selection→Adjuvant selection→Peptide vaccine synthesis→Immunization study→In vitro ...
Antibody Backbone: The Starting Point for ADC Design l Selection of antigen specificity Since the mechanism of ADCs begins with the binding of target cells, the antibody should have high specificity for the target antigen. Ideally, the antigen should be overexpressed on the surface of tumor cells and not expressed (or very low) ...
Targets can be divided into tumor-specific antigens (TSA) and tumor-associated antigens (TAA) according to their expression. Antigens that are only expressed in tumor cells but not in normal cells are tumor-specific antigens and the most ideal targets; antigens that are lowly expressed in normal tissues but ...
Selection of ADC Target Antigens Currently, the target antigens of approved ADC drugs are typically specific proteins that are overexpressed in cancer cells, including HER2, trop2, nectin4, and EGFR in solid tumors, and CD19, CD22, CD33, CD30, BCMA, and CD79b in hematological malignancies. Driven by basic research in oncology and immunology, ...
Here, using a genetic timestamping system in mice, we show that persistent PCs accrue in bone marrow at an approximately constant rate of one cell per hour over a period spanning several weeks after a single immunization with a model antigen. Affinity-based selection was evident in persisting PCs, reflecting a relative and dynamic rather than absolute affinity ...
In addition, oral administration of liposome-antigen formulations may enhance antigen delivery to antigen-presenting cells.Topical drug administrationLiposomes can reduce the side effects of topical drugs because they require only small doses when used as topical formulations. ...
As we all know, both antibodies and enzymes are protein molecules, and the binding of enzymes to substrates and the binding of antibodies to antigens are highly specific. But the fundamental difference between these two binding forms is that enzymes bind to high-energy transition-state molecules, while antibodies bind to antigens (ground-state molecules). ...
A combination of bioinformatics approach and computational tools are used to screen and select antigen sequences as potential T-cell epitopes of supertype human leukocyte antigens (HLAs) alleles. ...